18Nov2024 Read more DEA extends telemedicine flexibilities through 2025 On November 15, DEA announced the extension of current telemedicine flexibilities for prescription-controlled medications through the end of 2025. This includes substances such as buprenorphine and Adderall.
14Nov2024 Read more Researchers seek to understand AFib risk in Black adults Resting heart rate was associated with an increased risk of new-onset AFib for Black adults, according to a recent study published in JAMA Network Open.
8Nov2024 Read more Study ties lower anticonvulsant prescriptions to pharmacy closures While previously published findings pointed to a decline in adherence to cardiovascular drugs following community pharmacy closures, new research suggests a similar pattern with anticonvulsants.
25Oct2024 Read more Whooping cough cases are on the rise, says CDC CDC reports that cases of whooping cough in the United States have reached the highest level in 10 years, with West Coast and Middle Atlantic regions standing out as current hot spots.